These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 37330018)

  • 1. Predictive value of ASCVD risk score for mortality and major adverse cardiovascular events in the year following a COVID-19 infection among US Veterans.
    Guardino ET; Tarko L; Wilson PWF; Gaziano JM; Cho K; Gagnon DR; Orkaby AR
    Int J Cardiol; 2023 Sep; 387():131120. PubMed ID: 37330018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older.
    Orkaby AR; Driver JA; Ho YL; Lu B; Costa L; Honerlaw J; Galloway A; Vassy JL; Forman DE; Gaziano JM; Gagnon DR; Wilson PWF; Cho K; Djousse L
    JAMA; 2020 Jul; 324(1):68-78. PubMed ID: 32633800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real-world evidence study.
    Chen G; Farris MS; Cowling T; Pinto L; Rogoza RM; MacKinnon E; Champsi S; Anderson TJ
    Clin Cardiol; 2021 Nov; 44(11):1613-1620. PubMed ID: 34585767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between the 10-Year ASCVD Risk Score and COVID-19 Complications Among Healthy Adults (Analysis from the National Cohort COVID Collaborative).
    Khatib R; Glowacki N; Lauffenburger JC; Reddy A; Dennert K; Triscari D;
    Am J Cardiol; 2023 Sep; 202():201-207. PubMed ID: 37454637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Impact of Aging on Cardiovascular Risk in Women Military Service Members.
    Chen X; Ramanan B; Tsai S; Jeon-Slaughter H
    J Am Heart Assoc; 2020 Jun; 9(12):e015087. PubMed ID: 32515249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Atherosclerotic Cardiovascular Disease and Nonatherosclerotic Cardiovascular Disease Hospitalizations for Triglycerides Across Chronic Kidney Disease Stages Among 2.9 Million US Veterans.
    Soohoo M; Hashemi L; Hsiung JT; Moradi H; Budoff MJ; Kovesdy CP; Kalantar-Zadeh K; Streja E
    J Am Heart Assoc; 2021 Dec; 10(23):e022988. PubMed ID: 34729994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.
    Chew KW; Bhattacharya D; Horwich TB; Yan P; McGinnis KA; Tseng C; Freiberg MS; Currier JS; Butt AA
    J Viral Hepat; 2017 Oct; 24(10):814-822. PubMed ID: 28273386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Three Atherosclerotic Cardiovascular Disease Risk Scores With and Without Coronary Calcium for Predicting Revascularization and Major Adverse Coronary Events in Symptomatic Patients Undergoing Positron Emission Tomography-Stress Testing.
    Anderson JL; Le VT; Min DB; Biswas S; Minder CM; McCubrey RO; Knight S; Horne BD; Mason S; Lappe DL; Muhlestein JB; Knowlton KU
    Am J Cardiol; 2020 Feb; 125(3):341-348. PubMed ID: 31806210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics.
    Htoo PT; Tesfaye H; Schneeweiss S; Wexler DJ; Everett BM; Glynn RJ; Kim SC; Najafzadeh M; Koeneman L; Farsani SF; Déruaz-Luyet A; Paik JM; Patorno E
    JAMA Netw Open; 2022 Oct; 5(10):e2237606. PubMed ID: 36264574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Low-Density Lipoprotein Cholesterol and Cardiovascular Disease Risk Across Chronic Kidney Disease Stages (Data from 1.9 Million United States Veterans).
    Hashemi L; Hsiung JT; Arif Y; Soohoo M; Jackson N; Gosmanova EO; Budoff M; Kovesdy CP; Kalantar-Zadeh K; Streja E
    Am J Cardiol; 2022 May; 170():47-55. PubMed ID: 35300833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 associated mortality and cardiovascular disease outcomes among US women veterans.
    Tsai S; Nguyen H; Ebrahimi R; Barbosa MR; Ramanan B; Heitjan DF; Hastings JL; Modrall JG; Jeon-Slaughter H
    Sci Rep; 2021 Apr; 11(1):8497. PubMed ID: 33875764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.
    Rosenblit PD
    Curr Diab Rep; 2019 Jul; 19(8):61. PubMed ID: 31332544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Cardiovascular Disease Risk Factor Burden With Progression of Coronary Atherosclerosis Assessed by Serial Coronary Computed Tomographic Angiography.
    Han D; Berman DS; Miller RJH; Andreini D; Budoff MJ; Cademartiri F; Chinnaiyan K; Choi JH; Conte E; Marques H; de Araújo Gonçalves P; Gottlieb I; Hadamitzky M; Leipsic J; Maffei E; Pontone G; Shin S; Kim YJ; Lee BK; Chun EJ; Sung JM; Lee SE; Virmani R; Samady H; Stone P; Narula J; Bax JJ; Shaw LJ; Lin FY; Min JK; Chang HJ
    JAMA Netw Open; 2020 Jul; 3(7):e2011444. PubMed ID: 32706382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System.
    Vassy JL; Lu B; Ho YL; Galloway A; Raghavan S; Honerlaw J; Tarko L; Russo J; Qazi S; Orkaby AR; Tanukonda V; Djousse L; Gaziano JM; Gagnon DR; Cho K; Wilson PWF
    JAMA Netw Open; 2020 Jul; 3(7):e208236. PubMed ID: 32662843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.
    Erqou S; Papaila A; Halladay C; Ge A; Liu MA; Jiang L; Lally M; Menon A; Shah NR; Miech E; Virani SS; Zullo AR; Shireman TI; Longenecker CT; Ross D; Sullivan JL; Wu WC; Rudolph JL
    Am Heart J; 2022 Jul; 249():12-22. PubMed ID: 35318028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated Atherosclerotic Cardiovascular Disease Risk: Disparities and Severe COVID-19 Outcomes (from the National COVID Cohort Collaborative).
    Arif YA; Stefanko AM; Garcia N; Beshai DA; Fan W; Wong ND
    Am J Cardiol; 2022 Nov; 183():16-23. PubMed ID: 36175254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep Learning to Estimate Cardiovascular Risk From Chest Radiographs : A Risk Prediction Study.
    Weiss J; Raghu VK; Paruchuri K; Zinzuwadia A; Natarajan P; Aerts HJWL; Lu MT
    Ann Intern Med; 2024 Apr; 177(4):409-417. PubMed ID: 38527287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
    Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
    JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Interplay of the Global Atherosclerotic Cardiovascular Disease Risk Scoring and Cardiorespiratory Fitness for the Prediction of All-Cause Mortality and Myocardial Infarction: The Henry Ford ExercIse Testing Project (The FIT Project).
    Rifai MA; Qureshi WT; Dardari Z; Keteyian SJ; Brawner CA; Ehrman JK; Ahmed A; Sakr S; Virani SS; Blaha MJ; Al-Mallah MH
    Am J Cardiol; 2019 Aug; 124(4):511-517. PubMed ID: 31221461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib.
    Kristensen LE; Strober B; Poddubnyy D; Leung YY; Jo H; Kwok K; Vranic I; Fleishaker DL; Fallon L; Yndestad A; Gladman DD
    Ther Adv Musculoskelet Dis; 2023; 15():1759720X221149965. PubMed ID: 36777695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.